CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 731 shares at $2.70 ($1,975)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale CEO sold 5,394 shares at $2.02 ($10,894)
- 4 Planned sale SVP, Chief Financial Officer sold 474 shares at $2.02 ($957)
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 749 shares at $2.02 ($1,513)
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 713 shares at $2.15 ($1,535)
- 4 Planned sale CEO sold 5,603 shares at $2.15 ($12,064)
- 4 Planned sale SVP, Chief Financial Officer sold 461 shares at $2.15 ($993)
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 710 shares at $2.60 ($1,843)
- 4 Planned sale SVP, Chief Financial Officer sold 458 shares at $2.60 ($1,189)
- 4 Planned sale CEO sold 5,592 shares at $2.60 ($14,517)
- 4 Planned sale SVP, Chief Financial Officer sold 679 shares at $2.58 ($1,752)
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 5,121 shares at $2.49 ($12,757)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 18 · 351 filings